Maria Gazouli is an expert in Gastroenterology at National and Kapodistrian University of Athens (Greece). Maria Gazouli has authored 512 publications, the most recent in 2026. SLR score: 1,347 (community average: 125). How the SLR is computed.

LeadR Profile

1 347 ScienceLeadR Reputation 1347
Network Map

Gastroenterology

Subspecialties: Biochemistry - Oncology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

National and Kapodistrian University of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 512

Citations

Citations: 13 209 1st author: 51 Last author: 106 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Polyphenols and Flavonoids in microRNA-Regulated Pathways of Doxorubicin-Induced Cardiotoxicity: Mechanistic Evidence, Biomarker Potential and Translational Gaps.
PMID 42941994 — cells, micrornas, doxorubicin, biomarkers, cardiotoxicity, flavonoids, polyphenols, phytochemicals
Int J Mol Sci20260
DAMPs and PAMPs in the Perioperative Period: Danger Signaling, Immune Dysfunction, and Oncologic Implications.
PMID 42796413 — anesthesia, perioperative period, stress, physiological, neoplasms, inflammasomes, pathogen-associated molecular pattern molecules, biomarkers, reperfusion injury, immunosuppression therapy, perioperative medicine
Medicina (Kaunas)20260
Evaluation of Longitudinal CD40 and CD40L Changes During Adjuvant Breast Cancer Therapy and Their Association with Left Ventricular Dysfunction.
PMID 42512402 — breast neoplasms, ventricular dysfunction, neoplasms, ventricular dysfunction, left, breast, cd40 ligand, echocardiography, anthracyclines, therapeutics, trastuzumab
Cancers (Basel)20260
ExposoGenomics: integrating genome and exposome as jointly dynamic systems for causal discovery and precision health.
PMID 42482117 — genomics, genome, foundations, exposome
Hum Genomics20260
A quality-by-design engineering strategy for hybrid lipid-random copolymer nanoparticles optimization: methotrexate loading and effectiveness studies.
PMID 42482350 — methacrylates, nanoparticles, pharmaceutical preparations, liposomes, methotrexate, phospholipids
J Liposome Res20260

LeadR Networks

Main global connection map